This CJC-1295 DAC review covers what the long-acting peptide does, typical research dosages, reported side effects, and how it compares to no-DAC.
CJC-1295 DAC is a long-acting growth hormone-releasing hormone (GHRH) analog sold for research and used off-label by some people hoping to raise growth hormone and IGF-1 levels. Reviews of the peptide usually focus on how long a single injection lasts, how it compares with CJC-1295 without DAC, and what side effects users report. CJC-1295 DAC is not FDA-approved for human use in the United States, and no large human trial has confirmed its long-term safety.
What Is CJC-1295 DAC?
CJC-1295 DAC is a modified GHRH peptide. The DAC, or drug affinity complex, is a chemical addition that lets the peptide bind to albumin in the bloodstream, which keeps it active far longer than the unmodified version.
In laboratory research, the peptide is studied for its ability to signal the pituitary gland to release growth hormone. Because of the DAC group, a single dose can keep growth hormone and IGF-1 elevated for several days.
It is sold as a lyophilized powder, most often in vials of cjc 1295 dac 5mg, and it is labeled for research use only.
How CJC-1295 DAC Works
CJC-1295 DAC binds to GHRH receptors in the pituitary and triggers growth hormone release. The DAC portion attaches to albumin, slowing the breakdown of the peptide and producing a longer, steadier signal than natural GHRH.
That steady signal is why users describe it as the long-acting option. It is not growth hormone itself; it tells the body to produce more of its own.
What the research shows
Small early studies found that one dose raised growth hormone and IGF-1 for up to six days in healthy adults. Those studies measured hormone levels, not health outcomes, and they were short.
CJC-1295 DAC has not been shown to build muscle, burn fat, or improve recovery in controlled human trials.
Reported Benefits and Real-World Results
User reviews are mixed and rely on personal experience rather than clinical evidence. Commonly reported effects include better sleep, faster recovery, and gradual changes in body composition over several months.
People searching for cjc 1295 with dac before and after photos often land in bodybuilding forums, where logs are anecdotal and frequently include several other peptides, diet changes, or training programs.
What most reviews agree on:
- Effects build slowly and are modest on their own.
- Injection frequency is low compared with shorter-acting peptides.
- It is difficult to separate results from diet, training, and other compounds.
CJC-1295 DAC Dosage and Reconstitution
There is no FDA-approved human dose of CJC-1295 DAC. Much of what circulates online comes from cjc 1295 dac dosage per week reddit threads rather than published studies.
Community-reported ranges usually fall between 1 mg and 2 mg per week, split into one or two injections. Some users report that lower amounts feel just as strong because the DAC extends the peptide's activity.
cjc 1295 dac reconstitution follows the standard research peptide routine: add bacteriostatic water to the lyophilized powder, swirl gently, and refrigerate the mixed vial.
- Reconstituted peptide should be refrigerated and protected from light.
- Doses are drawn with an insulin syringe and measured in micrograms or milligrams.
- No standardized dosing exists, and self-dosing carries unknown risks.
CJC-1295 DAC vs CJC-1295 No DAC and Sermorelin
CJC-1295 with DAC is the long-acting version. CJC-1295 without DAC, often called mod GRF (1-29), clears the body in minutes and is usually injected more often. A cjc-1295 no dac vs sermorelin comparison usually comes down to half-life and injection frequency.
| Peptide | Approximate half-life | Typical research frequency | FDA status |
|---|---|---|---|
| CJC-1295 DAC | 6 to 8 days | 1 to 2 times per week | Not approved for human use |
| CJC-1295 without DAC | About 30 minutes | 1 to 3 times daily | Not approved for human use |
| Sermorelin | 10 to 20 minutes | Daily | Approved for diagnostic testing only |
Sermorelin has a shorter half-life than CJC-1295 without DAC, and both clear the body far faster than CJC-1295 with DAC.
Side Effects, Safety, and Legal Status
Reported side effects of CJC-1295 DAC include flushing, injection site irritation, increased hunger, headache, and water retention. Some users notice tingling or numbness in the hands, which can signal elevated growth hormone.
Because the peptide raises growth hormone and IGF-1, there is a theoretical concern about the long-term effects of sustained IGF-1 elevation, including changes in blood sugar and cell growth. No long-term human safety data exists for this peptide.
The FDA has not approved CJC-1295 DAC for human use, and it is sold only as a research chemical. Anyone considering it should talk with a licensed healthcare professional first.
Bottom Line
A fair CJC-1295 DAC review has to separate marketing claims from evidence. The peptide clearly raises growth hormone and IGF-1 in short studies, and its long half-life makes it convenient for people who dislike frequent injections.
What is missing is proof of meaningful benefit and long-term safety. Forum reviews are not a substitute for clinical data, and the risks of raising IGF-1 for months at a time without medical supervision are not well understood.
Frequently Asked Questions
Is CJC-1295 DAC FDA approved in the US?
No. CJC-1295 DAC is not FDA-approved for human use in the United States. It is sold as a research chemical only and is not a legal dietary supplement or prescription drug. Sermorelin is the only GHRH analog in this group with FDA approval, and that approval covers diagnostic testing only.
How often do people inject CJC-1295 DAC?
Because of the DAC group, the peptide stays active for several days, so community protocols often use one or two injections per week. There is no officially established human dose. Forum-reported amounts usually range from 1 mg to 2 mg weekly, but those numbers are not backed by large clinical trials.
What are the side effects of CJC-1295 DAC?
Commonly reported effects include flushing, headache, injection site reactions, increased appetite, and water retention. Some users notice tingling or numbness in the hands, which may reflect elevated growth hormone. Long-term safety data in humans is lacking, so anyone with health concerns should speak with a doctor.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.